ArticleFrontiers in oncology2022

Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer.

Jie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.